Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclesonide vs Fluticasone for AMP Responsiveness in Asthma
NCT00306163Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2006
- Primary completion
- Aug 2008
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciclesonide in asthma, sponsored by AstraZeneca. Started May 2006; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00306163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00306163.